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Analyses  of thymus-derived  (T)  lymphocytes that  induce  or  suppress  antibody 
responses have shown that these functions are mediated by sets ofT lymphocytes that 
express different  and characteristic patterns of cell surface glycoproteins  (1-3).  Ex- 
amination of these specific T  cell functions have also indicated that soluble mediators, 
or factors, can mimic the functions of intact T-suppressor or T-inducer ceils (4-14). 
However, analysis of these  materials has not  yet permitted  a  clear insight  into  the 
structural basis of antigen-specific T  cell function. 
A direct approach to this question requires large numbers of homogenenous T  cells 
for biochemical studies. So far, T  cell lymphomas have not proved so useful as B cell 
myelomas  (15,  16)  because  many  do  not  grow  well  in  culture  and  few  express 
immunological function (17,  18). Hybrids resulting from fusion of T  cells with tumor 
cells (19-24) usually express the phenotype of the tumor cell partner and tend to lose 
chromosomes in cell culture.  Analysis of immunologically active T-cell hybrids has 
also suggested that  with  few exceptions  (23),  these cells synthesize extremely small 
amounts of antigen-specific material (19,  21). 
Using a method that allows production of large numbers of antigen-specific inducer 
or suppressor T  cells, we have found that  all Ly-l÷2  -  clones so far examined carry 
inducer but not suppressor activity and synthesize a characteristic pattern of polypep- 
tides.  In  contrast,  Ly-2  +  clones  mediate  suppressor  but  not  inducer  activity  and 
synthesize a characteristic set of proteins that differs from T-inducer ceils (25). 
We describe here a clone of Ly-2  ÷ suppressor T  cells that expresses surface receptors 
specific for glycophorin from sheep erythrocytes  (SRBC). 1 Supernates  of this  clone 
contain  biosynthetically labeled  70,000-mol  wt proteins that  (a)  specifically bind to 
SRBC and (b) specifically and completely suppress primary anti-SRBC responses. 
Materials and Methods 
Animals.  C57BL/6  (B6) and BALB/c mice were obtained from The Jackson Laboratory, 
Bar Harbor, Maine. 
* Supported by grants AI-13600, AI-12184, and CA-26695 from the National Institutes of Health. 
:~ Yale University,  New Haven, Conn. 
1 Abbreviations used in  this paper: B6, C57BL/6 mice; BRBC, burro erythrocytes, BSA, bovine serum 
albumin; FACS, fluorescence-activated  cell sorter; FCS, fetal calf serum; HG, glycophorin peptides from 
human erythrocytes; HRBC, horse erythrocytes; mc, monoclonal; NP-40, Nonidet P-40; PBS, phosphate- 
buffered saline; PFC, plaque-forming cells; SDS, sodium dodecyl sulfate; SG, glycophorin peptides from 
sheep erythrocytes; SRBC, sheep erythrocytes; TNP, 2,4,6-trinitrophenol. 
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Antisera.  Lyt-l.2, Lyt-2.2, and  Ly-5.1  antisera, prepared as described elsewhere (26,  27), 
were kindly donated by Dr. F.-W. Shen MemoriaI-Sloan Kettering Cancer Center, New York; 
monoclonal (mc) anti-Thy-1-2 by Dr. Ed Clark, University of Washington, Seattle, Wash., and 
mc-anti Ly-1 and mc-anti Lyt-2 by Dr. J. Ledbetter and Dr. L. Herzenberg, Stanford University 
School of Medicine, Stanford, Calif. Expression of surface glycoproteins by each clone was 
determined  by  immunofluorescence  using  both  mc  antibodies  and  antisera  as  described 
previously (25, 28). 
Antigens and  Immunization.  SRBC,  horse  erythrocytes  (HRBC),  and  burro  erythrocytes 
(BRBC) were purchased from Colorado Serum Co., Denver, Colo. Mice were immunized i.v. 
with 2  ×  10  a erythroeytes in 0.25  ml balanced salt solution  1-3 wk before use. Glycophorin 
from  SRBC  and  HRBC  (>60%  homogeneous)  were obtained by eluting the corresponding 
bands from sodium dodecyl sulfate (SDS) polyarcylamide gels of ethanol-extracted erythrocyte 
membranes. The asialo form of sheep glycophorin was obtained by neuraminidase treatment 
of the eluted glycophorin. CH-2 peptide, (>80% homogeneous) corresponding to the N-terminal 
region of sheep glycophorin, was obtained after chymotryptic digestion of SRBC and purified 
as described elsewhere (29).  Human erythrocyte glycophorin as well as its N-terminal tryptic 
peptide, T-2, (amino acids 1-33) were purified to virtual homogeneity as described previously 
(29, 30). 
Preparation of Lymphoid Cell Populations 
Ly-l+2  -  CELLS.  Spleen cells from erythrocyte-immune donors were passed through nylon- 
wool columns according to the method of Julius et al. (31).  Ig-, Ly-l÷2  -  cells were positively 
selected from this cell population as follows 02, 33): Fisher petri dishes (Fisher Scientific Co., 
Pittsburgh, Pa.) were incubated with mc-anti-Ly-1 (12/xg/dish) and goat Ig (640/~g/dish) in 
10  ml for  12  h  before extensive washing with phosphate-buffered saline (PBS)-2% fetal calf 
serum (FCS); 5 ml of column-passed cells (107/ml) were incubated in these dishes for 60 min 
at 4°C with occasional shaking. After removal of nonadherent cells by swirling the plate gently, 
10 ml RPMI-1640 supplemented with 10% FCS was added and the plates were slowly rocked 
for an additional 30 rain at 37°(. After gentle ~ipetting, eluted cells were washed twice and 
incubated with anti-Lyt-2.2 and Lyt-3.2 (3 ×  10  cells/ml; final concentration of anti-Lyt sera: 
1:30)  followed by incubation for 40 rain at  37°C  with selected rabbit serum as a  source of 
complement. This procedure resulted in a  cell population -->98% Lyt-l+2  -, Ig- according to 
immunofluorescence using either mc-anti-Ly antibodies or conventional anti-Ly sera. 
B CELLS.  After positive selection of cells on anti-Fab-coated plates (33),  eluted cells were 
incubated with me-anti-Thy-l.2 (final dilution: 1:1,000),  anti-Lyt-l.2, and anti-Lyt-2.2 (final 
dilution of each:  1:30)  for 35 min on ice, washed, and incubated an additional 30 min with 
rabbit complement. Lack of residual T  cells was verified by immunofluorescence_using mc- 
anti-Thy-1  antibody,  as  well  as  by  the  absence  of anti-SRBC  plaque-forming cell  (PFC) 
responses after in vitro stimulation by SRBC. 
Biological Assays  for Suppressive Activity.  The ability of supernates of cloned T cell populations 
to inhibit in vitro ~eneration of anti-SRBC PFC was determined by adding supernate material 
•  10  B  cells from nonimmune  to mixtures of 10  Ly-1 cells from SRBC-immune donors and 
donors in a final vol of 0.2 ml. These cell cultures were stimulated with 10  s SRBC for 5 d before 
anti-SRBC PFC were enumerated (34). Inhibition of anti-SRBC helper function was tested by 
preincubating 105 Ly-1 cells from SRBC-immune donors (obtained as described above) with 
different superuate preparations for 24-36 h. Cells were then washed three times with PBS-2% 
FCS, counted and tested for SRBC-specific helper function after addition to cultures containing 
l0  s B cells and SRBC. In all cases, anti-erythrocyte PFC and total PFC were determined from 
triplicate euhures (35-37). 
Generation of Cl.Ly23/4 Cells.  T  cells from the B6 mice immunized with SRBC were treated 
with anti-Lyt-1.2 and complement twice before incubation in plastic dishes coated with sheep 
glycophorin (10 #g/dish). Adherent cells were released by vigorous pipetting, distributed into 
microwells (Falcon 3040  microtiter plates;  Falcon Labware, Div.  Becton,  Dickinson & Co., 
Oxnard, Calif.), and expanded using culture conditions that  have been described elsewhere 
(25). The CI.Ly23/4 line was derived from a colony that arose in wells seeded with  1-10 cells; 
after 2 mo of growth, the clone was derived by micromanipulation of a single cell (25). 
Binding of Soluble Antigen to Cloned Cell Populations.  Cloned cell populations were washed three 1248  ANTIGEN-SPECIFIC  T-SUPPRESSOR CLONES 
times  in  PBS-2%  FCS  and  resuspended  at  5  X  105  cells/ml  in  the  same  medium.  After 
incubation with various radiolabeled antigens at 4°C for 1 h, the cells were washed five times 
Ifi:PBS-2% FCS and radioactivity in the cell pellet was determined. 
'; l~ternal Labeling of Cloned Cells.  Production of labeled supernatant material from cloned cells 
Was carried  out in serum-free conditions as follows:  cells  from continuously growing T  cell 
ClSties were washed three times and incubated at l0  s cell/ml in methionine- and glutamine-free 
RPMI- 1640 medium that was supplemented with 2 mM glutamine, 5/~g/ml human transferrin, 
5/~g/ml bovine insulin, 20 U/ml aprotinin and 100-200 #Ci [SSS]methionine  (1,000 Ci/mmol). 
After  4  h  at  37°C,  unlabeled  methionine  was  added  to  bring  the  final  concentration  of 
mi~thionine  to 1 mM. Cells were pelleted by centrifugation, washed repeatedly with PBS, and 
:st~red  at -70°C for further use. 0.1  mg/ml ovalbumin was added to the supernate as carrier 
prbtein before centrifugation at high speed (100,000 g for 1 h) before use. 
Estimation oft& Amount of Protein in Cl.Ly23/4 Supernatant Fractions.  The approximate amount 
io~protein in different supernatant fractions was estimated from the radioactivity of the samples 
:acb0rding to the following assumptions:  (a)  methionine  =  1% protein content;  (b)  10  n cpm 
methionine  ffi  1 #g  protein. Because  intracellular  methionine  levels  can  affect  the  above 
e~firaates,  cells  were routinely pulsed  with  [anS]methionine  of different  specific activities  to 
determine  the  degree  of dilution  of radiolabeled  methionine.  Because  the  results  of these 
experiments varied up to one order of magnitude the figures of protein concentration given in 
tO~s~report are accurate within a single order of magnitude, and are most useful for comparison 
purposes within a single experiment. 
"  ~  ~",.r.,.  ,  35  . Bmdmg of  S-labeled Supernatant Mater~al to Eo~throcytes.  SRBC, HRBC, or BRBC  (107/ml) 
w~re incubated with supernatant material from different T cell clones for 2 h at 4°C. The cells 
ygare pelleted by centrifugation (1,000 g), washed twice with PBS, and when relevant, dissolved 
in. Laemmli sample buffer (38) for subsequent analysis on polyacrylamide gels or scintillation 
counting. 
• ~Affinity Chromatography of Clone Cl.Ly23/4 Supernate.  Different glycophorins were conjugated 
t0'Sepharose 4B with cyanogen bromide (2 mg protein/ml beads) (39). Cell supernate material 
~r serum-free media (see above) was mixed with the immunoadsorbent beads (0.1 ml beads/ml 
supgrnate) in 5-ml syringe columns before incubation for 2 h at 4°C with occasional shaking. 
The eolumns were then  extensively washed  with  PBS,  followed by elution  with  Sorensen's 
glyeine-HCl (pH 2.4) buffer and immediate neutralization with excess Tris-HCl (2 M, pH 7.2). 
~r,he suppressive activity of eluted  cell  supernatant  material  was always compared with the 
effects of serum-free media that had been eluted under identical conditions (buffer control). 
'~/Polyacrylamide Gel Electrophoresis.  Unless otherwise indicated, eleetrophoresis was carried out 
irL0.7-mM thick slab gels using a modification of the method of Laemmli (38). Briefly, 25-/~1 
aikl~uots of the samples for analysis were mixed with an equal volume of a solution containing 
160 mM Tris-HCl, pH 6.8; 20% glycerol; 4% SDS; 0.4% bromophenol blue; and the material 
was boiled  for 5  min.  When reducing conditions were desired,  200  mM dithiothreitol  was 
~dded. Gels containing  12.5% acrylamide and 0.1% SDS were subjected to electrophoresis at 
i20V constant  voltage until  the tracking dye reached the bottom of the gel.  The gels were 
stained with Coomasie Blue and destained with 25% isopropanol-10% acetic acid solution. The 
me~hod of fluorographic treatment of Laskey and Mills (40) was routinely used to enhance gel 
Sensitivity  and to reduce exposure time before drying. Radioautographs obtained using Kodak 
i X~-Omat XR-5 films (Eastman Kodak Co., Rochester, N. Y.) were scanned in a Joyce-Loebl 
:densitometer (Joyce, Loebl and Co., Gateshead-on-Tyne  England). 
:~  Results 
:~,,Generation  of Clone  Cl.Ly23/4.  T  cells  from SRBC-immune  B6 mice were treated 
:width  anti-Lyt-l.2  plus  complement  and  eluted  from  dishes  coated  with  SRBC 
glyeophorin  before  initiation  of clonal  growth.  Clones  were  screened  by  testing 
' metabolically labeled  supernates  for (a)  binding to SRBC, HRBC, or human eryth- 
rOcytes and  (b)  inhibition  of in vitro production of anti-gRBC  PFC by mixtures of 
Ly-1  cells  and  B  cells.  A  clone  was  considered  positive  if [aSS]methionine-labeled 
st~pernate  polypeptides bound to SRBC but not  HRBC or human erythrocytes and FRESNO, NABEL, McVAY-BOUDREAU, FURTHMAYER, AND CANTOR  1249 
inhibited  the PFC response to SRBC but not HRBC or BRBC.  One of eight clones 
tested, termed CI.Ly23/4, was positive by both criteria. 
The cell surface phenotype of CI.Ly23/4 cells (determined by immunofluorescence) 
is Thy-I  +, Lyto2  +, Ly-5  +, Ig-, NK-1- and this phenotype has been stable for >12 mo 
of in vitro growth. Samples of these cloned cells are routinely frozen for storage; cells 
are  grown  from  thawed  samples  to  >10  s  without  detectable  change  in  surface 
phenotype, function, or pattern of polypeptide synthesis  (25).  Expression of Ly-1  is 
ambiguous:  indirect  immunofluorescence generally indicated  that a  portion of cells 
(10-30%)  emitted fluorescence slightly above background levels on the fluorescence- 
activated cell sorter (FACS). 
Clone Cl.Ly23/4  Expresses Receptors for SRBC Glycophorin (Fig. 1).  Cells  from the 
CI.Ly23/4 clone were tested for binding to lzSI-labeled chymotryptic peptide  (CH2) 
that  corresponds to the  N-terminal or external  portion  of SRBC  glycophorin  (30). 
CI.Ly23/4 cells bound the CH2 peptide from SRBC glycophorin but did not bind the 
N-terminal portion of glycophorin from human erythrocytes (T-2)  (Fig.  1A). Other 
cloned T-cell populations did not bind either material (data not shown).  Specificity 
of binding was verified by competition with different unlabeled glycophorins; excess 
intact cold glycophorin from sheep erythrocytes but  not  from erythrocytes of other 
species inhibited binding (Fig.  1 B). 
Demonstration of Antigen-binding Peptides in Supernates of Cl.Ly23/ 4 Cultures (Tables I and 
H and Fig. 2).  Cloned cells were pulsed with  [~S]methionine  for 4  h  in serum-free 
media (Materials and Methods).  After eentrifugation (100,000 g), the supernate was 
incubated with different erythrocytes, (107/1  ml for 2 h  at 4°C).  4-8% of total cpm 
present in the supernate of CI.Ly23/4 cells bound to SRBC; <2% bound to HRBC or 
BRBC.  Other  cloned  cell  populations  from  SRBC-immune  donors  that  expressed 
different cell surface phenotypes (Thy- 1  +, Ly- 1  +2-; Thy- 1  +, Ly- 1-2-, NK- 1  +) did not 
release antigen-specific binding proteins into the medium under the same conditions. 
Moreover, supernates from a  cloned Thy-1 ÷, Ly-l-2  + cell population obtained from 
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Fie.  1.  Binding  of erythrocyte glyeophorins to CI.Ly23/4 cells (A) Saturation binding. 3 X 105 
cells in 0.6 ml PBS-2% FCS were incubated with different amounts of l~I-labeled chymomtryptic 
peptide (CH-2) from SG (O) or its HG equivalent, the T-3 tryptic peptide (O), for 1 h at 4°C. (B) 
Competition binding. 3 X 105 cells in 0.6 ml PBS-2% FCS were incubated with 20 ng I~I-SG CH- 
2 for 10 rain at 4°C before addition of the indicated amounts of unlabeled glycophorins  from either 
SRBC (O) human erythrocytes (0) or HRBC (A) for 60 rain. 1250  ANTIGEN-SPECIFIC T-SUPPRESSOR CLONES 
TABLE  I 
Binding of [nsS]Methionine-labeled Supernates  flora Cloned Cells to 
E~ythrocytes 
Clone super- 
nate 
Counts per minute bound 
SRBC  HRBC  BRBC  TNP-BSA  BSA 
CI.Ly23/4  3,450  1,250  1,140  ND  ND 
CI.Ly23/11  6,220  1,700  1,340  ND  ND 
CI.NKI 1  310  770  ND  ND  ND 
CI.Lyl/4  1,760  1,940  ND  ND  ND 
C1.Ly23/18"  1,350  1,450  1,380  4,350  1,285 
[ssS]Methionine  internally labeled supernatant peptides (5 X  10  4 cpm) from 
7  different cloned populations was incubated with 10  erythrocytes (Materials 
and  Methods)  or added  to a  polyvinyl plate  coated with bovine serum 
albumin  (BSA) or TNP-BSA. Although 2% of the counts per minute in 
supernates of CI.Ly23/4 bound to BRBC or HRBC, no discrete internally 
labeled peptide was detected after electrophoresis  of ~5,000 cpm of BRBC 
or HRBC-bound material on polyacrylamide gels, in contrast to polyacryl- 
amide gel electrophoresis  of 5,000 cpm of SRBC-bound material (Fig. 2). 
*  TNP-specific clone. 
:]: Not done. 
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FIG.  2.  SDS~olyacrylamide  gel  electrophoresis  of CI.Ly23/4  supernatant  material  bound  to 
erythrocytes.  [  S]Methionine-labeled supernate (10  n cpm) from CI.Ly23/4 cells was incubated with 
107 of the indicated erythrocytes (RBC). After washing twice with PBS, erythrocyte-bound material 
was dissolved in Laemmli sample buffer and 5,000 cpm of each subjected to electrophoresis  in 12.5% 
acrylamide  gels.  Densitometric  scans  of the  radioautographs  of these  gels  after  fluorography 
treatment are shown.  15, 24, 45, 68 =  15,000, 24,000, 45,000, 68,000 mol wt, respectively. 
donors immune  to a  different antigen 2,4,6-trinitrophenyl  (TNP)  bound  TNP  but not 
SRBC.  (Table I). 
Internally labeled supernates  from C1.Ly23/4  bound  to SRBC,  HRBC,  or human 
erythrocytes  (5  ×  103  cpm  each)  were analyzed  by electrophoresis  in SDS-polyacryl- 
amide gels under reducing conditions.  Densitometric scanning of the radioautographs 
of the  bound  material  demonstrated  that  a  major  polypeptide  of ~70,000  mol  wt 
bound  SRBC  (Fig. 2). No discrete polypeptide was detected in material that  adhered FRESNO,  NABEL,  McVAY-BOUDREAU, FURTHMAYER, AND CANTOR  1251 
TABLE II 
Effect of Dzfferent Glycophorins on Binding of lnternally Labeled Cl.Ly23/ 4 
Supernate to SRBC 
[~S]Methionine super-  Percent inhibi- 
Amount  nate bound  tion specific 
Glycophorin  added  cpm bound to 
SRBC  BRBC  SRBC 
#g/ml 
None  --  1,600  540  Standard 
SG  10  498  583  100 
SG  1  1,410  ND  18 
Horse glycophorin  10  1,471  637  12 
SG (asialo)  10  1,206  ND  36 
SG (CH-2 peptide)  4  830  ND  70 
HG (T-3 peptide)  4  1,567  ND  3 
[~S]Methionine-labeled CI.Ly23/4 supernatant proteins (2 ×  104 epm in 0.5 
ml)  were  incubated with 5  ×  10  s SRBC or BRBC  in the presence  of the 
indicated amount of glycophorins.  The specific counts per minute bound to 
SRBC were obtained by subtracting the counts per minute bound to BKBC 
(540) from the counts per minute bound to SRBC. 
TASLE III 
C1.Ly23/4 Clone Supernate Suppresses Anti-SRBC PFC Responses 
Dilution of  Anti-SRBC  Percent-  Total PFC/t0  s  Percent- 
CI.Ly23/4  PFC/10  e cells  age of  cells  age of 
supernate  control  control 
No supernate  2,011 "4" 140  1,032 3= 48 
10  -2  0 :t= 0  0  451 3= 24  45 
10  -a  315 ± 28  16  892 :l: 35  88 
10  -4  1,307 zl: 85  52  1,038 "4- 59  100 
Supernate from CI.Ly23/4 cells was added to a mixture of 105 SRBC-immune 
Ly-l+2  -  helper T  cells, I0  e nonimmune B cells, and 10  s SRBC.  Anti-SRBC 
PFC and total PFC were enumerated 5 d later. Results are shown as the mean 
PFC "4- SE of triplicate cultures (Materials and Methods). 
to HRBC  or human  erythrocytes despite 2 wk of exposure of gels containing the same 
total counts per minute as SRBC-bound  material. 
Binding of asS-labeled supernatant material to SRBC was a  result of a  glycophorin 
recognition, because binding to 5  ×  106 SRBC was inhibited by 10 #g of intact sheep 
glycophorin or 4 #g of the CH-2 peptide, but was not inhibited by human  glycophorin 
(Table  II).  This  inhibition cannot  be  attributed  to  nonspecific properties  of glyco- 
phorin  molecules  from  sheep  erythrocytes  (e.g.,  increased  hydrophobicity)  because 
background levels of cpm bound to another erythrocyte, BRBC, were not affected by 
addition of SRBC  glycophorin. Sugar residues present on the glycophorin molecule 
apparently play an important role in its antigenicity because neuraminidase treatment 
of sheep erythrocyte glycophorin greatly reduced its ability to inhibit binding (Table 
II). 
SRBC Glycophorin-spedfic Supernatant Molecules from Cl. Ly23/4 Suppress the Anti-SRBC 
Response (Table III, Figs. 3-5).  Highly diluted supernates obtained from 106 CI.L623/ 
4 cells inhibited the production of anti-SRBC Ig but not total Ig secretion by mixtures 
of Ly- 1 cells and B  cells. However,  higher concentrations of supernate also inhibited 1252  ANTIGEN-SPECIFIC T-SUPPRESSOR CLONES 
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Fio.  3.  Suppressive  activity  of CI.Ly23/4  supernate  after elution  from  SG  or  HG  columns. 
CI.Ly23/4 supernate (10 ml)  was applied to  1-ml glycophorin columns. After intensive washing 
with PBS, passed (O, l)  and acid-eluted material (0, O) were tested for suppression of in vitro anti- 
SRBC (aSRBC) PFC and total PFC responses. Results are shown as the mean suppression  ±  SE. 
PFC responses incubated with buffer controls were 850 +  60 anti-SRBC PFC and  10,530 +  795 
total PFC. amt, amount. 
total Ig secretion as measured by a  reversed PFC assay (Table III). To determine 
whether  antigen-binding molecules  were  responsible  for  this  suppressive  activity, 
supernates of CI.Ly23/4 cultures were applied to Sepharose 4B columns coupled with 
glycophorin from SRBC (SG) or human erythrocytes (HG). 
Suppressive  activity of material  retained  on  SG-  or  HG-coated  columns  was 
quantitated by adding graded amounts of the eluted protein (estimated from [aSS]- 
methionine content; Materials and Methods) to SRBC-stimulated cultures. As little 
as 1 ng of material eluted from SG-coated columns inhibited 75% of the anti-SRBC 
PFC response (Fig. 3); suppressive activity was not detectable in supernate that did 
not adhere to SG-coated columns. Material eluted from HG-coated columns contained 
suppressive activity at high concentrations (50  ng/ml)  (Fig. 3).  This latter activity 
might be accounted for by cross-reactive binding to HG, or by nonspecific interactions 
with HG. We favor the latter explanation because suppressive activity retained on 
HG-columns  but  not  on  SG-columns  could  be  eluted  by  Nonidet  P-40  (NP-40) 
nonionic detergent  (0.3%) (Fig.  4).  To  determine whether  suppressive  activity in 
supernatant  material  that  passed  through HG-coated columns after washing with 
PBS could bind to SG, this material was reapplied to SG-coated columns (Fig. 5). 
These data show that passage of CI.Ly23/4 supernate through HG-coated columns 
before elution from SG-coated columns resulted in approximately a  50-fold increase 
in  specific suppressive  activity/ng of protein:  as  little as 0.02  ng of this  material 
inhibited 80% of the anti-SRBC PFC response. 
Cellular Target of Clone Cl. sly23~4 Suppressive  Activity (Fig. 6).  The above information 
indicates  that  material  synthesized by  CI.Ly23/4  (a)  binds  to  sheep  erythrocyte 
glycophorin and (b)  inhibits in vitro generation of anti-SRBC PFC by mixtures of 
Ly-1 cells and B cells. To determine which of these cell populations is the target of 
suppression, Ly-1 ceils or B ceils were preincubated with the SG-eluted fraction of 
CI.Ly23/4 supernate for 36 h.  After washing four times, Ly-1 cells were tested for 
helper activity and B cells were tested for antibody-forming activity. Preineubation of FRESNO,  NABEL, McVAY-BOUDREAU, FURTHMAYER, AND CANTOR 
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Fro.  4.  Effect of  low concentrations of NP-40 on the retention of  suppressive activity on glycophorin 
columns. CL.Ly23/4 supernates were applied to glycophorin columns as described in Fig.  3. The 
columns were then washed sequentially with 10-ml aliquots of PBS containing increasing amounts 
of NP-40  (0-1%)  followed by final elution with  I0 ml glycine-HCl, pH 2.4, buffer.  The different 
fractions  (after dialysis  against  PBS)  were tested  for suppression  of anti-SRBC  PFC  at  a  final 
dilution of (1:20). 
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FIo.  5.  Suppressive  activity of CI.Ly23/4 supernate  passed  through columns with HG binds to 
columns coated with SG.  C:L.Ly23/4  supernate was passed  through  HG-coated columns before 
application  to SG-coated columns.  SG-coated columns were washed with PBS  (passed  fraction) 
before elution with low pH buffer (eluted fraction).  The passed and eluted fractions were tested for 
suppression  of anti-SRBC  (aSRBC)  PFC or total PFC. PFC responses  of cell cultures incubated 
with control buffer were 950:1:35 anti-SRBC PFC and 7,850 :l: 430 total PFC. 
Ly-1  cells with CI.Ly23/4  supernate  material  eliminated subsequent  helper activity; 
preincubation  of  B-cells  did  not  affect  subsequent  antibody-forming  activity.  In 
addition,  this  analysis  demonstrates  that  suppression  of Ly-I  cell helper  activity by 
CI.Ly23/4  supernate  requires the presence of antigen  (SRBC). 1254 
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F]o.  6,  Cellular target of CI.Ly23/4 suppression and requirement for antigen (agn).  Ly-1 cells 
from SRBC immune donors (10  ~) or B cells (106) from unimmunized donors were preincubated 
with 5 or 0.5 ng of material eluted from SGocoated columns with or without l0  s SRBC for 36 h at 
37°C. After washing the cells twice with PBS-2% FCS, l0  s Ly-I cells were tested for anti- (-) SRBC 
helper T  cell activity after addition to l0  s fresh B cells and l0  s SRBC. Preincubated B cells were 
tested for antibody-forming activity after mixing with 105 Ly-1 cells from SRBC-immune donors 
and  106 SRBC. aSRBC PFC and total PFC were enumerated 4 d later. Cultures containing Ly- 
1+2  -  cells preincubated with buffer control produced 720 :t= 80 anti-SRBC PFC and 8,640 ±  870 
total  PFC.  Cultures containing B cells  preincubated with buffer control produced  1,400 ±  85 
aSRBC PFC and 8,930 ±  1,250 total PFC. 
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Fio.  7.  Sephacryl S-200 column chromatography of SG-binding proteins from CI.Ly23/4 super- 
hates. Internally labeled CI.Ly23/4 supernatant material was eluted from SG-coated columns by 
low  pH buffer and fractionated by Sephacryl 8-200  chromatography on  100- ×  2-cm  columns 
equilibrated with PBS containing 2% glycerol,  1 mM, phenylmethylsulfonylfluoride,  and 100 mM 
KCI.  Each 2-ml fraction was tested for radioactivity and for suppression (final dilution:  1:100) of 
the anti-SRBC PFC resource  in cultures containing SRBC and mixtures of Ly-l+2  -  cells and B 
cells. K, 1,000 mol wt; STI, soybean trypsin inhibitor. FRESNO, NABEL, McVAY-BOUDREAU, FURTHMAYER, AND CANTOR  1255 
TABLE IV 
Specific Inhibition of lnduter T Cell Function by 70,O00-mol  wt Polypeptides 
That Bind to SG 
70,000-tool  Anti-erytlarocyte  PFC/l0  s B eens 
Source of Ly-  1 cells  wt fraction 
added  Anti-SRBC  Anti-HRBC 
ng 
SRBC-immune donors  0  2,758 +  160  -- 
SRBC-immune donors  0.5  168 + 30  -- 
HRBC-immune donors  0  --  2,800 + 240 
HRBC-immune donors  0.5  --  2,780 :t: 330 
Fractions 56-58 from Sephacryl 8-200 column chromatography (Fig. 7) were 
pooled and concentrated. Ly-l+2  - helper T cells (10  s) from either SRBC- or 
HRBC-immune donors were preincubated for 24 h with 0,5 ng of this material 
and either  l0  s SRBC or HRBC before testing for helper T cell activity as 
indicated Fi~. 6. 
A  70,O00-mol wt Fraction of Cl.Ly23/4 Supernate Specifically Suppresses T Helper Activity 
for SRBC but No Other E~ythrocytes (Fig.  7 and Table IV).  Because suppressive activity 
in  CI.Ly23/4  supernate  was  lost  after  passage  through  SG-  but  not  HG-coated 
columns, we asked whether the molecular weight of suppressive material corresponded 
to  the  molecular weight  of material  that  bound  to  SRBC.  After  Sephacryl  S-200 
chromatography of material eluted from SG-coated columns, suppressive activity was 
concentrated in a few fractions having the same molecular weight as antigen-binding 
material (Fig. 7,  70,000 tool wt). 
To  determine whether  suppression  of Ly-1 cells by the  70,000-mol  wt supernate 
material was SRBC specific, Ly-1 cells from donors immune to SRBC or HRBC were 
preincubated  with  the  homologous  erythroeyte  and  the  70,000-mol  wt  fraction 
obtained after elution from Sephacryl columns; this incubation diminished subsequent 
anti-SRBC but not anti-HRBC helper activity (Table IV). Similarly, preincubation 
of Ly-1 cells from donors immune to BRBC  did not inhibit subsequent  anti-BRBC 
helper activity (data not shown). 
Discussion 
We have generated cloned cells bearing the Thy-1 +, Ly-l±2+3  + surface glycoprotein 
pattern (CI.Ly23/4). This cell line was derived by single cell micromanipulation and 
has been propagated in continuous culture for >12 mo. Cells of this cloned line have 
maintained stable expression of cell surface gene products  (Ig-Ly/b2-; Thy-l+; Ly- 
1±2  +, Ly-3  +, Ly-5+; NK-I-, Qa-5-), and stable biologic function. Cells of this clone, 
in  contrast  to T  suppressor clones  that  had been  derived  after elution  from dishes 
coated with other antigens, bound specifically to a chymotryptic peptide (CH-2) (Fig. 
1),  which  represents  the external  portion  of the  SG molecule  (29,  30).  Because the 
CH-2 peptide does not contain amino acids that span the erythrocyte membrane, it 
is considerably  less  hydrophobic than  the entire molecule.  Because CI.Ly23/4 cells 
bound the CH2 peptide at least as efficiently as the whole molecule, it is likely that 
binding  reflects  immunologic  recognition  of the  external  portion  of the  molecule 
rather than hydrophobie interactions. These data  (Fig.  1 A  and B) demonstrate that 
cloned T  cells express specific and saturable receptor activity for free antigen; we do 
not know whether major histocompatibility complex products also contribute to the 1256  ANTIGEN-SPECIFIC T-SUPPRESSOR CLONES 
affinity of this antigen-specific binding. Although we have not performed extensive 
binding studies, data obtained so far indicate that each T  cell binds ~5  ×  104 SG 
molecules. Assuming one glycophorin molecule bound per receptor, this figure is -  10- 
fold lower than the numbers of cell-bound receptors  thought to be expressed on B 
cells (41). 
This analysis also demonstrates that, in addition to carrying receptors for antigen 
at its membrane surface, CI.Ly23/4 cells produce antigen-binding polypeptides (Table 
I). Although we have not formally demonstrated that these internally labeled poly- 
peptides are secreted,  the findings that  (a)  virtually all antigen-binding activity is 
present in the supernatant fraction after centrifugation at 100,000 g (Fig. 2) and (b) 
very little is detectable in membrane or cytoplasmic fractions (M. Fresno, L. McVay- 
Boudreau, and H. Cantor, manuscript in preparation)  speaks against the possibility 
of binding by supernatant material randomly shed from the cell. Analysis of meta- 
bolically labeled material in supernates demonstrated that a molecular species having 
an apparent 70,000 mol wt (Fig. 2) accounted for almost all specific binding and that 
binding of this 70,000-mol wt material to sheep erythrocytes was completely inhibited 
by glycophorin-enriehed peptides from SRBC but not human erythrocytes or HRBC 
(Table II). 
Approximately 2-3% of internally labeled proteins synthesized by CI.Ly23/4 cells 
is  found in  the supernatant  fraction and  ~10%  of this represents  antigen-binding 
material.  By contrast,  extensive analysis of clones of prethymic cells,  thymocytes, 
inducer celts and NK cells has shown that these cell types do not synthesize 70,000- 
mol wt antigen-binding polypeptides (25). These findings suggest that synthesis and 
secretion of these antigen-binding 70,000-mol wt peptides is a specialized function of 
CI.Ly23/4 eetts. 
The combined use of the sheep erythrocyte and different glycophorin molecules has 
allowed analysis of the fine specificity of binding by the 70,000-mol wt polypeptides. 
Binding to SRBC is likely to reflect recognition of glycophorin determinants because 
it is inhibited by low concentrations of intact molecules as well as the N-terminal 
portion of this molecule. The latter peptides inhibit less efficiently than the whole 
molecule.  This  may  indicate  the  contribution  of an  additional  sequence  of the 
glycophorin to binding or may simply reflect differences in the conformation between 
the intact glycophorin and the chymoeryptic peptide. Interestingly, sialic acid residues 
on glycophorin molecules play a major role in its recognition by both 70,000-mol wt 
peptides (Table II) and the intact cells (data not shown). 
It is generally accepted that suppressor effector cells express the Ly-1-23  + surface 
phenotype (1-3, 42).  After incubation with mc-Lyt-1 or conventional Ly-1 antisera, 
a  portion of C1.Ly23/4 cells (~20%)  are read as slightly above background in the 
FACS. This does not reflect the surface phenotypes of two distinct clones because 
CI.Ly23/4 was derived after single cell mieromanipulation and regrowth  (25).  Ly- 
1+2  + cells in uncloned T  cell populations may produce antigen-specific material (43) 
and have been implicated as precursors of suppressor cells (42).  Because only about 
one-fifth of C1.Ly23/4 cells express low amounts of Ly-1, an intriguing possibility is 
that cells within this clone may continuously differentiate in cell culture as follows: 
Ly-l+2  + (20%) ~  Ly-l-2  + (80%). 
The  results  reported  here  demonstrate  that  internally  labeled  peptides  from 
C1.Ly23/4 specifically suppress in vitro antibody responses. These suppressive peptides FRESNO, NABEL, McVAY-BOUDREAU, FURTHMAYER, AND CANTOR  1257 
bind specifically to columns coated with SG (Figs. 3 and 5) and have an ~70,000 mol 
wt (Figs. 2 and  7). Although small amounts of suppressive activity are detectable in 
material  bound  to  columns  coated  with  HG,  this  binding  is  sensitive  to  NP-40 
detergent, unlike binding to columns coated with SG. 
The 70,000-mol wt polypeptides described here can be classified as final mediators 
of T suppression because they directly inhibit helper activity of Ly-1 cells. By contrast, 
most products from T  suppressor cells that have been studied stimulate other T  cells 
to  augment  T-suppression  primarily  by  activating  Ly-l+2  ÷  cells  to  amplify  the 
generation of suppression from Ly-l-2  ÷ cells (4, 5, 7-12). 
Perhaps the most striking finding reported here is that polypeptides from a single 
T  cell clone can completely preempt the antibody response to a  foreign cell. These 
studies do not rule out the possibility that suppression is carried out by a  family of 
polypeptides, and that only a small fraction of these polypeptides bind specifically to 
molecules  on  the  erythrocyte surface.  According  to  this  idea,  interactions  among 
erythrocyte-specific peptides and other molecules are required to completely suppress 
the response to the whole erythrocyte. Alternatively, binding of a single polypeptide 
to a unique determinant on a foreign erythrocyte may preempt the primary antibody 
response  to  the  entire cell.  To distinguish  between  these  alternatives,  and  to  gain 
insight into the structural basis of  specific immunologic suppression, we have examined 
the biologic activity of biosynthetically labeled molecules that have been purified to 
homogeneity. This analysis is described in the accompanying report (44). 
Summary 
We  have  generated  continuously  propagatable  T  lymphocyte  clones  to  study 
antigen-specific T  cell functions. All Ly-2  + clones mediate suppressive activity and 
secrete a  characteristic pattern of polypeptides that differs from Ly-2- T  cell clones. 
Cells of one clone, CI.Ly23/4, specifically bind glycophorin from sheep erythrocytes 
(SRBC). After incubation with  [~S]methionine, supemate material  from this clone 
also contains biosynthetically labeled 70,000-mol wt proteins that specifically bind to 
SRBC  and  this  binding  is  inhibited  by  glycophorin  from  sheep  but  not  other 
erythrocytes. These antigen-binding  70,000-tool  wt  peptides  specifically and  com- 
pletely suppress primary anti-SRBC responses generated by mixtures of primed Ly- 
1+2  -  ceils and B cells. Suppression by these antigen-binding peptides reflects direct 
inhibition of T-helper activity. 
Received  for publication 17 December 1980. 
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